Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.5100 (4.05%) ($27.5000 - $28.9700) on Thu. Jul. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.84% (three month average) | RSI | 82 | Latest Price | $28.5100(4.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2.3% a day on average for past five trading days. | Weekly Trend | HALO advances 6.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(48%) IWC(45%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.42% in a week (0% probabilities). VIXM(-32%) UUP(-15%) VXX(-14%) TLT(-3%) IYT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.42% (StdDev 2.84%) | Hourly BBV | 0 () | Intraday Trend | 3% | | | |
|
5 Day Moving Average | $26.66(6.94%) | 10 Day Moving Average | $25.99(9.7%) | 20 Day Moving Average | $24.76(15.15%) | To recent high | 0% | To recent low | 75.4% | Market Cap | $3.897b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |